1. Home
  2. RYAN vs TVTX Comparison

RYAN vs TVTX Comparison

Compare RYAN & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryan Specialty Holdings Inc.

RYAN

Ryan Specialty Holdings Inc.

HOLD

Current Price

$32.56

Market Cap

4.1B

Sector

Finance

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$45.81

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYAN
TVTX
Founded
2010
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.1B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
RYAN
TVTX
Price
$32.56
$45.81
Analyst Decision
Buy
Strong Buy
Analyst Count
17
13
Target Price
$50.88
$40.62
AVG Volume (30 Days)
2.2M
2.0M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
1.48%
N/A
EPS Growth
N/A
92.89
EPS
N/A
N/A
Revenue
$3,051,126,000.00
N/A
Revenue This Year
$15.78
$44.76
Revenue Next Year
$12.49
$35.51
P/E Ratio
$86.72
N/A
Revenue Growth
21.28
N/A
52 Week Low
$29.28
$13.88
52 Week High
$68.70
$48.61

Technical Indicators

Market Signals
Indicator
RYAN
TVTX
Relative Strength Index (RSI) 49.32 58.73
Support Level $31.50 $41.43
Resistance Level $34.41 $48.60
Average True Range (ATR) 1.50 2.02
MACD 0.08 -0.24
Stochastic Oscillator 49.26 65.70

Price Performance

Historical Comparison
RYAN
TVTX

About RYAN Ryan Specialty Holdings Inc.

Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: